Collegium Pharmaceutical, Inc. Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised
Collegium Pharmaceutical, Inc. (COLL) reported Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised of $947.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans · last filed 2026-08-06
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2026-06-30 was $0.00.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2026-03-31 was $947.00K, a 87.15% increase year-over-year.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-12-31 was $0.00.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for the quarter ending 2025-09-30 was $857.00K, a 81.95% increase year-over-year.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2025 was $1.36M, a 64.81% increase from fiscal 2024.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2024 was $827.00K, a 79.78% increase from fiscal 2023.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2023 was $460.00K, a 36.50% increase from fiscal 2022.
- Collegium Pharmaceutical, Inc. proceeds, issuance of shares, share-based payment arrangement, excluding option exercised for fiscal 2022 was $337.00K, a 55.36% decline from fiscal 2021.
| Period end | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 3 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 6 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 9 month | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised 12 month |
|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $947.00K 10-Q · filed 2026-08-06 | $947.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $947.00K 10-Q · filed 2026-05-07 | $947.00K derived: sum of 2 quarters · filed 2026-05-07 | $1.80M derived: sum of 3 quarters · filed 2026-05-07 | $1.80M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $857.00K derived: sum of 2 quarters · filed 2026-02-26 | $857.00K derived: sum of 3 quarters · filed 2026-08-06 | $1.36M 10-K · filed 2026-02-26 |
| 2025-09-30 | $857.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $857.00K derived: sum of 2 quarters · filed 2026-08-06 | $1.36M 10-Q · filed 2025-11-06 | $1.36M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $506.00K 10-Q · filed 2026-08-06 | $506.00K derived: sum of 3 quarters · filed 2026-08-06 | $977.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $506.00K 10-Q · filed 2026-05-07 | $506.00K derived: sum of 2 quarters · filed 2026-05-07 | $977.00K derived: sum of 3 quarters · filed 2026-05-07 | $977.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $471.00K derived: sum of 2 quarters · filed 2026-02-26 | $471.00K derived: sum of 3 quarters · filed 2026-02-26 | $827.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $471.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $471.00K derived: sum of 2 quarters · filed 2025-11-06 | $827.00K 10-Q · filed 2025-11-06 | $827.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $356.00K 10-Q · filed 2025-08-07 | $356.00K derived: sum of 3 quarters · filed 2026-02-26 | $647.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $356.00K 10-Q · filed 2025-05-08 | $356.00K derived: sum of 2 quarters · filed 2026-02-26 | $647.00K derived: sum of 3 quarters · filed 2026-02-26 | $647.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $291.00K derived: sum of 2 quarters · filed 2026-02-26 | $291.00K derived: sum of 3 quarters · filed 2026-02-26 | $460.00K 10-K · filed 2026-02-26 |
| 2023-09-30 | $291.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $291.00K derived: sum of 2 quarters · filed 2024-11-07 | $460.00K 10-Q · filed 2024-11-07 | $460.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08 | $169.00K 10-Q · filed 2024-08-08 | $169.00K derived: sum of 3 quarters · filed 2025-02-27 | $303.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $169.00K 10-Q · filed 2024-05-09 | $169.00K derived: sum of 2 quarters · filed 2025-02-27 | $303.00K derived: sum of 3 quarters · filed 2025-02-27 | $303.00K derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $134.00K derived: sum of 2 quarters · filed 2025-02-27 | $134.00K derived: sum of 3 quarters · filed 2025-02-27 | $337.00K 10-K · filed 2025-02-27 |
| 2022-09-30 | $134.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $134.00K derived: sum of 2 quarters · filed 2023-11-07 | $337.00K 10-Q · filed 2023-11-07 | $337.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-03 | $203.00K 10-Q · filed 2023-08-03 | $203.00K derived: sum of 3 quarters · filed 2024-02-22 | $600.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $203.00K 10-Q · filed 2023-05-04 | $203.00K derived: sum of 2 quarters · filed 2024-02-22 | $600.00K derived: sum of 3 quarters · filed 2024-02-22 | $600.00K derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $397.00K derived: sum of 2 quarters · filed 2024-02-22 | $397.00K derived: sum of 3 quarters · filed 2024-02-22 | $755.00K 10-K · filed 2024-02-22 |
| 2021-09-30 | $397.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | $397.00K derived: sum of 2 quarters · filed 2022-11-03 | $755.00K 10-Q · filed 2022-11-03 | $755.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $358.00K 10-Q · filed 2022-08-04 | $358.00K derived: sum of 3 quarters · filed 2023-02-23 | $759.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $358.00K 10-Q · filed 2022-05-10 | $358.00K derived: sum of 2 quarters · filed 2023-02-23 | $759.00K derived: sum of 3 quarters · filed 2023-02-23 | $759.00K derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $401.00K derived: sum of 2 quarters · filed 2023-02-23 | $401.00K derived: sum of 3 quarters · filed 2023-02-23 | $758.00K 10-K · filed 2023-02-23 |
| 2020-09-30 | $401.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-04 | $401.00K derived: sum of 2 quarters · filed 2021-11-04 | $758.00K 10-Q · filed 2021-11-04 | $758.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $357.00K 10-Q · filed 2021-08-05 | $357.00K derived: sum of 3 quarters · filed 2022-02-24 | $730.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $357.00K 10-Q · filed 2021-05-06 | $357.00K derived: sum of 2 quarters · filed 2022-02-24 | $730.00K derived: sum of 3 quarters · filed 2022-02-24 | $730.00K derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $373.00K derived: sum of 2 quarters · filed 2022-02-24 | $373.00K derived: sum of 3 quarters · filed 2022-02-24 | $817.00K 10-K · filed 2022-02-24 |
| 2019-09-30 | $373.00K 10-Q · filed 2019-11-06 | $373.00K derived: sum of 2 quarters · filed 2020-08-05 | $817.00K 10-Q · filed 2020-11-05 | $817.00K derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-05 | $444.00K 10-Q · filed 2020-08-05 | $444.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.05M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $444.00K 10-Q · filed 2020-05-07 | $444.00K derived: sum of 2 quarters · filed 2021-02-25 | $1.05M derived: sum of 3 quarters · filed 2021-02-25 | $1.05M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $607.00K derived: sum of 2 quarters · filed 2021-02-25 | $607.00K derived: sum of 3 quarters · filed 2021-02-25 | $1.12M 10-K · filed 2021-02-25 |
| 2018-09-30 | $607.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-06 | $607.00K derived: sum of 2 quarters · filed 2019-11-06 | $1.12M 10-Q · filed 2019-11-06 | $1.12M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $510.00K 10-Q · filed 2019-08-07 | $510.00K derived: sum of 3 quarters · filed 2020-02-27 | $978.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $510.00K 10-Q · filed 2019-05-08 | $510.00K derived: sum of 2 quarters · filed 2020-02-27 | $978.00K derived: sum of 3 quarters · filed 2020-02-27 | $978.00K derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $468.00K derived: sum of 2 quarters · filed 2020-02-27 | $468.00K derived: sum of 3 quarters · filed 2020-02-27 | $1.14M 10-K · filed 2020-02-27 |
| 2017-09-30 | $468.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $468.00K derived: sum of 2 quarters · filed 2018-11-08 | $1.14M 10-Q · filed 2018-11-08 | |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $673.00K 10-Q · filed 2018-08-08 | ||
| 2017-03-31 | $673.00K 10-Q · filed 2018-05-09 | |||
| 2016-12-31 | $442.00K 10-K · filed 2019-02-27 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |